Neuroscience
Drug may delay MS disability for some
An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds.
Jan 9, 2019
0
37
News tagged with ms drug
Genetics
Genetic marker for drug risk in multiple sclerosis offers path toward precision medicine
A team of researchers has uncovered a specific gene variant associated with an adverse drug reaction resulting in liver injury in a people with multiple sclerosis (MS). It is the first time researchers have been able to establish ...
Jul 16, 2018
0
46
Neuroscience
New guideline: Start taking MS drugs early on
For most people, it's better to start taking drugs for multiple sclerosis (MS) early on rather than letting the disease run its course, according to a new guideline for treating MS from the American Academy of Neurology. ...
Apr 23, 2018
0
6
Neuroscience
What happens when women stop MS treatment during pregnancy?
Two new studies look at the effects of stopping the newer, stronger drug natalizumab for multiple sclerosis (MS) during pregnancy. Natalizumab is generally prescribed for people with MS who have not responded to or cannot ...
Feb 7, 2018
0
3
Neuroscience
Antidepressant may help combat the course of multiple sclerosis
The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remissions. As yet, drugs for this type of MS have been ...
Dec 20, 2017
0
61
Neuroscience
MS drug mitoxantrone may be linked to increased risk of colorectal cancer
The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study published in the May 11, 2016, online issue of Neurology, the medical journal of the American ...
May 11, 2016
0
6
Neuroscience
French firm announces multiple sclerosis drug breakthrough
French biotechnology company MedDay on Friday announced encouraging results for a multiple sclerosis (MS) drug trial, saying it decreased its progress and in some cases led to a "significant improvement" for sufferers.
Apr 24, 2015
0
335
Medications
Clinical trials of anti-LINGO-1 drug to treat eye damage from MS appears to show mixed results
(Medical Xpress)—Biogen Idec Inc has released preliminary results of a phase II clinical trial (called RENEW) meant to test the effectiveness of using an anti-LINGO-1 drug called BIIB033, to treat eye damage that occurs ...
Neuroscience
HIV infection linked to lower multiple sclerosis risk
HIV infection is linked to a significantly lower risk of developing multiple sclerosis (MS), indicates observational research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Aug 4, 2014
0
1
Medications
FDA investigating PML in patient taking MS drug
(HealthDay)—The U.S. Food and Drug Administration is investigating the possible association between a rare brain infection and the multiple sclerosis (MS) drug Gilenya (fingolimod), according to a drug safety alert issued ...
Aug 31, 2013
0
0
